Could This Be the First Disease-Modifying Drug in Bronchiectasis?

By News Health
3 months Ago

(MedPage Today) — CHICAGO — Brensocatib (Brinsupri) appeared to have a disease-modifying effect on structural lung changes in non-cystic fibrosis bronchiectasis at its higher dose, a CT substudy of the ASPEN trial showed.
At the 25-mg dose…

Source link : https://www.medpagetoday.com/meetingcoverage/chest/118083

Author :

Publish date : 2025-10-22 17:20:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

What New Warning Did the FDA Call for on Flu Shots?

Trends in Skilled Nursing Facilities; Abortion Pill's Regulatory History

Easing AI and Wearables Regulation Is a Risky Move

The Healthcare Debate Is Back in Washington. It Never Really Went Away.

First treaty to protect the high seas comes into force

Tylenol in Pregnancy Not Tied to Autism, Rigorous Review Shows